S&P 500

5.459,10

1,11%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
TetraLogic Pharmaceuticals Corporation (CE) (TLOG)
TetraLogic Pharmaceuticals Corporation (CE) (TLOG) Notícias

TLOG

TetraLogic Pharmaceuticals (CE) (TLOG)

TetraLogic Pharmaceuticals Corporation (CE)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:TLOG

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
16/02/2021	08:30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
27/06/2018	17:26	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
04/08/2017	16:20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	19:29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	19:29	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	19:27	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	15:13	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
03/11/2016	15:11	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
02/11/2016	18:30	GlobeNewswire Inc.	TetraLogic Announces Agreements to Sell SMAC mimetic and HDAC inhibitor assets to Medivir and to Restructure its Convertible ...	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
28/04/2016	07:21	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
16/03/2016	18:19	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
10/02/2016	17:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
06/01/2016	19:11	GlobeNewswire Inc.	TetraLogic Pharmaceuticals Announces Data on Lead Clinical Programs	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
09/11/2015	10:00	GlobeNewswire Inc.	TetraLogic Pharmaceuticals Announces Clinical Data on Birinapant to be Presented at the 57th Annual American Society of Hemat...	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
04/11/2015	19:01	GlobeNewswire Inc.	TetraLogic Reports Third Quarter Financial Results and Provides Clinical Programs Update	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
02/11/2015	10:00	GlobeNewswire Inc.	TetraLogic Announces the Opening of an IND for SHAPE Gel in Alopecia Areata	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
25/08/2015	07:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
06/05/2015	13:52	GlobeNewswire Inc.	TetraLogic Announces Termination of Public Offering	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
06/05/2015	11:14	GlobeNewswire Inc.	TetraLogic Announces Temporary Halt of Chronic Hepatitis B Trial	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
01/05/2015	09:56	GlobeNewswire Inc.	TetraLogic Announces Pricing of $25 Million Public Offering	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
30/04/2015	17:01	GlobeNewswire Inc.	TetraLogic Announces Public Offering of Common Stock	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
21/04/2015	09:00	GlobeNewswire Inc.	TetraLogic Announces Publication of Two Papers Describing Birinapant's Preclinical Activity in Chronic Hepatitis B	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
20/04/2015	09:00	GlobeNewswire Inc.	TetraLogic and Merck to Collaborate on the Evaluation of Birinapant in Combination With KEYTRUDA(R) (pembrolizumab) in Solid ...	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
09/04/2015	11:11	GlobeNewswire Inc.	TetraLogic to Present at the 14th Annual Needham Healthcare Conference	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
30/03/2015	15:50	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
26/02/2015	18:10	GlobeNewswire Inc.	TetraLogic Reports 2014 Financial Results and Provides Clinical Programs Update	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
26/02/2015	13:48	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
17/02/2015	18:33	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
16/01/2015	09:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)
02/01/2015	15:57	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:TLOG	TetraLogic Pharmaceuticals Corporation (CE)